Celsion Long. The oncology company Celsion Corporation, which has a portfolio of innovative treatments for cancer, is paving the way for higher prices for its shares, CFDs. The current sad situation in the field of the global pandemic Covid 19 is resulting in a reduction in cancer treatment in mainstream workplaces and a move to private clinics. Celsion itself is one of the few to own patented products for successful treatment of this deadly disease. The current outlook for the rise in the price of CFDs, shares is at levels above 1 euro.
Chart and table source: WebTrader